Article information
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
K. Albain, V. Rusch.
Concuttent cisplatin (DDP), VP-16, and chest irradiation followed by surgery for stages IIIA and IIIB non small cell lung cancer: A Southwest Oncology Group (SWOG) Proc Am Soc.
Clin Oncol, 10 (1991), pp. 244
[2.]
K.S. Albain, V.W. Rusch, J.J. Crwley, et al.
Concurrent cisplatin/etoposide plus radiotherapy followed by surgery for stages IIIA(N2) and IIB non small cell lung cancer: mature results of Southwest Group Phase II Study 8805.
J Clin Oncol, 13 (1995), pp. 1880
[3.]
K. Albain, V. Rusch, J. Crowley.
Long term survival after concurrent cisplatin/etoposide plus radiolherapy followed by surgery in bulky, stages IIIAN2 and HIB non small cell lung cancer- 6-year outcomes from Southwest Oncology Group Proc ASCO, (1999), pp. 467a
[4.]
K.S. Albain.
Induction Chemotherapy with or without Radioterapy followed by surgery in Non-Small Cell Lung Cancer in Progress and Perspectives in the treatment of Lung Cancer, pp. 53-71
[5.]
K.S. Albain, H.I. Pass.
Induction Therapy for locally advanced non small cell lung cancer in Lung Cancer Principles and Practice, pp. 798-820
[6.]
D.C. Betticher, S.F. Schmitz, et al.
Neoadjuvant chemotherapy with docetaxcs and cisplatinin in patients with non small cell lung cancer, stage IIIA N2 is highly active with few toxicities, pp. 473a
[7.]
J.D. Bitran, H.M. Golomb, et al.
Protochemotherapy in non small cell lung carcinoma Na attempt to increase surgical resectability and survival.
Cancer, 57 (1986), pp. 44
[8.]
P.A. Bunn, J. Mault, K. Kelly.
Adjuvant and Neoadjuvant Chemotherapy for Non Small Lung Cancer.
Chest, 117 (2000), pp. 119s-122s
[9.]
P.A. Bunn.
A randomized trial of four chemolherapy regimens in advanced non small cell lung cancer, pp. 495
[10.]
J.H. Bulzebruck, R. Bopp, P. Drings.
New aspects in the staging of lung cancer: Prospective validation of the International Union Against Cancer TNM classification.
Cancer, 70 (1992), pp. 1202-1210
[11.]
R.L. Burkes, F.A. Shepherd, R.J. Ginsberg, et al.
Induction chemotherapy with MVP in patients with stage IIIA(N2) unresectable non small cell lung cancer: the Toronto experience.
Proc Am Soc Clin Oncol, 327 (1994),
[12.]
R.L. Burkes, F.A. Shepherd.
Induction chemotherapy with MVP in patients with stage IIIA (TI-3 N2MO) unrcsectable non small cell lung cancer. The Toronto experience,
[13.]
R. Cameron, R.J. Ginsberg.
Induction therapy and surgery for locally advanced stage IIIA (N2) non small cell lung cancer in Lung Cancer, pp. 78-95
[14.]
N.C. Choi.
Management of stage III Non small cell Lung Cancer: Progress in Preoperative Chemoradiotherapy.
Am Society Clinical Oncology, (1998),
[15.]
N.C. Choi, R. Carey.
Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concunent chernotherapy in stage IDA non small cell lung cancer.
J Clin Oncol, 15 (1997), pp. 712
[16.]
N.C. Choj, R.W. Carey, M. Myojin, et al.
Preoperative chemoradiotherapy using concurrent boost radiation and resection for good responders in stage IIIB (T4 or N3) non small cell lung cancer: A feasibility study.
Lung Cancer, (1997), pp. 291
[17.]
H. Choy, W. Akerley, H. Safran, et al.
Multiinstitutional phase II trial of paclitaxel, calboplatin and concurrent radiation therapy fot locally advanced non small cell lung cancer.
J Clin Oncol, 16 (1998), pp. 3316
[18.]
S. Darwish, V. Minotti, L. Crino.
Neoadjuvanl cisplatin and etoposide for stage IIIA (clinical N2) non small cell lung cancer.
AM J Clin Oncol, 17 (1994), pp. 64
[19.]
A. Depierre, B. Mllleron, B. Lebeau, et al.
Phase III trial of neoadjuvant chemotherapy in resectable stage I (except TI NO), II, IIIA non-small cell lung cancer. The French experience.
Proc Am Soc Clin Oncol, 18 (1999), pp. 465a
[20.]
R.T. Eagan, C. Ruud, R.E. Lee, et al.
Lung Cancer Study Group. Pilot study of induction therapy with cyclophosphamide. doxorubicin and cisplatin (CAP) and chest irradiation prior to thoracotomy intitially mopemble stage III MO non small cell lung cancer.
Cancer Treat Rep, 71 (1987), pp. 895
[21.]
W. Eberhart, Wilke.
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hiperfractionated accelerated radiotherapy and definitive surgery in locally advanced non small cell lung cancer. Mature results of a phase II.
J Clin Oncol, 17 (1999), pp. 622
[22.]
M.J. Edelman, D.R. Gandara.
Multimodality therapy in stage III non small cell lung cancer.
Ann Thorne Surg, 61 (1996), pp. l564-1574
[23.]
A.D. Elias, A.T. Skarin, R. Gonin.
Neoadjuvant treatment of stage III non small lung cancer.
Am J Clin Oncol, 17 (1994), pp. 26-36
[24.]
A.D. Elias, A.T. Skarin, et al.
Neoadjuvant therapy for surgically staged IIIAN2 non small cell lung cancer.
Lung Cancer, 17 (1997), pp. 147
[25.]
L.P. Faber, C.K. Kittle, W.H. Warren, et al.
Preoperative chemotherapy and irradiation for stage III non small cell lung cancer.
Ann Thorne Surg, 47 (1989), pp. 669
[26.]
J.Á. Figueroa, J. Jackson, J. Rinehart.
Neoadjuvant paclitaxel and carboplatin by definitive locoregional treatment in stage III non small cell lung cancer.
[27.]
J. Fleck, J. Camargo, D. Godoy, et al.
Chemoradiation therapy versus chemotherapy alone as a neoadjuvante treatment for stage III non small cell Lung cancer Phase III prospective randomized trial.
Proc Am Soc Cli Oncol, 12 (1994), pp. 333
[28.]
W.C. Fowler, C.J. Langer, et al.
Post-operative complications after combined neoadjuvant treatment of lung cancer.
Ann Thorne Surg, 55 (1993), pp. 986-989
[29.]
J.H. Goldie.
Scientific basis for adjuvant and neoadjuvant chemotherapy.
Sermin Oncol, 14 (1987), pp. 1-7
[30.]
D. Gruenwald, T. Le Chevalier, R. Arriagada.
Results of surgical resection in stage IIIB non small cell lung cancer (NSCLC) after concomitant induction chemoradiotherapy.
Lung cancer, (1997), pp. 280
[31.]
R. Inculet, C. Scoti, A.R. Dar, et al.
Phase III study comparing chemotherapy and radiation therapy with preoperative chemotherapy and surgical resection in patients with non small cell lung cancer with spread to mediastinal lymph nodes: a Radiation Therapy Oncology Group Study (RTOG).
Lung Cancer, 18 (1997), pp. 65
[32.]
C.J. Langer, B. Movsas, R. Hudes, et al.
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non small cell lung cancer.
Sem One, 24 (1997), pp. S12-S89
[33.]
K.V. Mattson, G. Tenvelde, K. Krofta, et al.
Taxotere as neoadjuvant therapy for radieally-treatable stage III NSCLC. Preliminary results.
[34.]
N. Martini, M.G. Kris.
Preoperative chemotherapy for stage IIIA(N2) lung cancer. The Sloan-Kettering experience with 136 patients.
Ann. Thorne Surg, 55 (1993), pp. 1365
[35.]
C.F. Mountain.
Revisions in the international system for staging lung cancer.
Chest, III (1997), pp. 1710
[36.]
T. Naruke, T. Goya, R. Tsuchiya, et al.
The importance of saugery to non small cell carcinoma of lung with mediastinal lymph node metastasis.
Ann Thorne Surg, 46 (1988), pp. 603-610
[37.]
H.I. Pass, H. Pogrebniak, et al.
Randomized trial of neoadjuvant therapy for lung cancer: interim analysis.
Ann Thorne Surg, 53 (1992), pp. 993
[38.]
K.M.W. Pisters, M.G. Kris, R.J. Gralla, et al.
Pathologic complete response in advanced non small cell lung cancer following pre-operative chemotherapy: implications for the design of future non small cell lung cancer combined modality trials.
J Clin Oncol, II (1993), pp. 1757-1762
[39.]
R. Rosell, J. Gomez Codina, C. Camps.
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non small cell lung cancer.
N Engl J Med, 330 (1994), pp. 153
[40.]
J. Roth, F. Fossella, R. Komaki, et al.
A randomized trial comparing perlopcra1ivc chemotherapy and surgery with surgery alone in resectable stage III non small cell lung cancer.
J Natl Cancer Inst, 86 (1994), pp. 673
[41.]
J.A. Roth, E.N. Atkinson, F. Fossell, et al.
Long term follow up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non small cell lung cancer.
Lung Cancer, 21 (1998), pp. 1
[42.]
V.W. Rusch, I.N.K.S. Alba.
Surgical resection of stage Illa and stage IIIB non small cell lung cancer after concurrent induction chemoradiotherapy: A Southwest Oncology Group trial.
J. Thorac Cardiovasc Surg, 105 (1993), pp. 97-106
[43.]
F.A. Shepherd, D. Camey.
Treatment of NSCLC: Chemotherapy in Textbook of Lung Cancer edited, pp. 213-242
[44.]
F.A. Shepherd, M.R. Johnston, D. Payne, et al.
Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non small cell lung cancer: A National Cancer Institute of Canada Clinical Trials Group Study.
Br J Cancer, 78 (1998), pp. 683
[45.]
R.J. Schilder, M. Goldberg, et al.
Phase II trial of induction high dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non small cell lung cancer.
Lung Cancer, 27 (2000), pp. 37-45
[46.]
A. Skarin, M. Jochelson, T. Sheldon.
Neoadjuvant chemotherapy in marginally resectable stage III MO non small cell lung cancer: Long-term follow-up.
J Surg Oncol, 40 (1989), pp. 266-274
[47.]
T.A.W. Splinter, A. Kirkpatrick, et al.
Randomized trial of surgery versus radiotherapy in patients with stage IIIA non small cell lung cancer after a response to induction chemotherapy. Intergroup study 08941.
Lung Cancer, 18 (1997), pp. 62-63
[48.]
T.A.W. Splinter, Smite, P. Postmus.
A randomizes phase tl trial of neoadjuvant chemotherapy foil wed by surgery versus surgery alone in patients with stage I, II and IIIA NO non small cell lung cancer. Preliminary analysis.
Lung Cancer, 18 (1997), pp. 66
[49.]
G.M. Strauss, E.H. Baldini.
Multimodality therapy for stage IIIA and IIIB Non-small Cell Lung Cancer in Lung Biology in Health and Disease- Multimodality Treatment of Lung Cancer, pp. 207-223
[50.]
D.J. Sugarbaker, J. Bemdon, et al.
Results of Cancer and Leukemia Group B Protocol 8935. A Multi-instìtutional phase II trimodality trial for stage IIIA (N2) non small cell lung cancer.
J Thorac Cardiovasc Surg, 109 (1995), pp. 473-485
[51.]
E.E. Vokes, K.A. Leopold, et al.
A randomized phase II study og gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy and concomitant chemoradiotherapy for unresectable stage III non small cell lung cancer, pp. 459a
[52.]
G. Taylors, M. Trybula, P.D. Bonomi.
Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localizes stage Ill, non small cell lung cancer.
Ann Thorac Surg, 43 (1987), pp. 87-91
[53.]
E. Eixejra.
Quimioterapia do carcinoma pulmonar de não pequenas células - Oncologia Pneumológica de, pp. 145-152
[54.]
P.I. Weiden, S. Piantadosi.
Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage W non small cell lung cancer. A phase II study of Lung Cancer Study Group.
J Nat Cancer Inst, 83 (1991), pp. 266-273
[55.]
J. Yashar, A.B. Weitberg.
Preoperativechemotherapy and radion therapy for stage IDA carcinoma of the lung.
Ann Thorac Surg, 53 (1992), pp. 445-448
[56.]
N.V. Zandwijk, L. Crino, et al.
Phase II study of gemcitabine plus cisplatin as induction regimen for patients with stage IIIA non small cell lung cancer by EORTC (08958), pp. 468a
Copyright © 2000. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Issue 4—Impact of air pollution on COVID-19 mortality and morbidity: An epidemiological and mechanistic review
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options